NCT07435896

Brief Summary

Decisions regarding tracheostomy and percutaneous endoscopic gastrostomy (PEG) in the intensive care unit (ICU) are frequently associated with substantial uncertainty, decisional conflict, and psychosocial burden among patients' relatives. Inadequate or non-tailored information may negatively influence anxiety levels, decision satisfaction, and subsequent adaptation to care responsibilities. Differences in communication patterns and educational background may further affect how families perceive the risks, benefits, and long-term implications of these procedures. This prospective study aims to evaluate the impact of relatives' educational level and different information delivery methods on anxiety, decision satisfaction, and the overall decision-making process related to tracheostomy and PEG in the ICU setting. The findings are expected to contribute to the development of structured, education-level-tailored information strategies to improve shared decision-making and family-centered care in critical care practice.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

March 15, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

2 months

First QC Date

February 16, 2026

Last Update Submit

February 21, 2026

Conditions

Keywords

Percutaneous Endoscopic GastrostomyTracheostomyIntensive Care Unit

Outcome Measures

Primary Outcomes (1)

  • Change in Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A) Score

    Anxiety levels of first-degree relatives will be assessed before and after the standardized information process using the Hospital Anxiety and Depression Scale (HADS), Turkish validated version. The HADS consists of 14 items, with the Anxiety subscale (HADS-A) comprising 7 items. The HADS-Anxiety subscale score ranges from 0 to 21, with higher scores indicating greater anxiety severity (worse outcome). The primary endpoint will be the change in HADS-Anxiety subscale score, calculated as post-information score minus pre-information score.

    Immediately before information delivery and immediately after completion of the information session (same day).

Secondary Outcomes (3)

  • Mean Total Score of the Family Satisfaction in the Intensive Care Unit Questionnaire (FS-ICU-24)

    After completion of the decision-making process (within 24-48 hours following the information session).

  • Decision-Making Process Evaluation

    Within 24-48 hours after the decision regarding tracheostomy and/or PEG.

  • Demographic and Clinical Variables

    At enrollment (baseline).

Study Arms (3)

Group E1

includes first-degree relatives of ICU patients indicated for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG) who have a self-reported educational level of primary school or below.

Group E2

includes first-degree relatives of ICU patients with an indication for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG) who have a self-reported educational level of secondary school or high school.

Group E3

includes first-degree relatives of ICU patients with an indication for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG) who have a self-reported educational level of university degree or higher.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

First-degree relatives of adult ICU patients with an indication for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG) at Elazığ Fethi Sekin City Hospital. Participants are individuals directly involved in the medical decision-making process and responsible for providing consent for the procedures.

You may qualify if:

  • First-degree relative of an ICU patient with an indication for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG)
  • Age ≥ 18 years
  • Able to understand and communicate in Turkish
  • Provides written informed consent
  • Responsible for or involved in the medical decision-making process

You may not qualify if:

  • Cognitive impairment or psychiatric condition interfering with questionnaire completion
  • Refusal to participate
  • Prior participation in this study
  • Inability to complete study questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2026

First Posted

February 27, 2026

Study Start

March 15, 2026

Primary Completion

May 15, 2026

Study Completion

June 15, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to the single-center design of the study and the inclusion of sensitive psychosocial and decision-making data from patients' relatives. Although data will be analyzed in anonymized form, sharing individual-level data may pose potential risks to participant confidentiality. Aggregate results will be made publicly available through scientific publication.